January 8, 2021
Trailblazer KRAS treatment filed with FDA
Amgen has filed its trailblazer KRAS inhibiting drug treatment with the FDA for a group of lung cancer patients with an aggressive form of the disease.
PharmaPhorum
Research News
Latest Advances in Lung Cancer Research
Explore our curated selection of the latest breakthroughs in lung cancer research.
Get the latest lung cancer research news directly in your inbox.
Learn more about:
- the latest science in lung cancer
- stories about living with lung cancer
- how LCFA is working to fund more lung cancer research grants
LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers. Human-reviewed, AI-created content is used to create some of the summaries for the articles listed.